"/> Novus Biologicals™ Peptide bloquant d’anticorps EV… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps EVER2

Réf. : BL-RE-083703Réf. fabricant : 18266616 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
147138
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76903. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 14 amino acids near the center of human EVER2.

Points forts

Source

Synthetic

(Accession #: AAM44454) The EVER2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-083703
Réf. fabricant18266616
Gene ID (Entrez)147138
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76903. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneepidermodysplasia verruciformis 2, Epidermodysplasia verruciformis protein 2, EV2, EVER2MGC102701, EVIN2FLJ43684, FLJ40668, MGC40121, transmembrane channel-like 8, transmembrane channel-like protein 8
Symbole de gène(s)TMC8
Type de produitEVER2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne14 amino acids near the center of human EVER2
Une question, une configuration particulière ?
Contactez-nous pour un devis.